文献速递关节外科创伤骨科

万古霉素与头孢他啶骨水泥作为膝关节假体周围感染潜在有效治疗

Vancomycin and Ceftazidime in Bone Cement as a Potentially Effective Treatment for Knee Periprosthetic Joint Infection.
PubMed 文献 · J Bone Joint Surg Am · 2017-01-01

本研究通过体外及体内模型确定膝关节假体周围感染的最佳载抗生素骨水泥配方。载万古霉素与头孢他啶的骨水泥体外抗菌活性持续时间不短于其他组合,并植入8例慢性膝关节假体周围感染患者,关节液样本对ATCC株和临床分离株均有活性。结论认为该配方提供广谱抗菌能力,是潜在有效治疗措施。

要点

  • 载万古霉素与头孢他啶骨水泥体外抗菌活性持续时间不短于其他抗生素组合。
  • 8例慢性膝关节假体周围感染患者植入该骨水泥间隔器后,关节液对ATCC株和临床分离株有活性。
  • 作者结论:该配方体外和体内均提供广谱抗菌能力,为潜在有效治疗措施。

核心结论

  • 载万古霉素与头孢他啶的骨水泥在体外和体内均提供广谱抗菌能力,被证明是膝关节假体周围感染治疗的潜在有效治疗措施。

研究设计与样本

  • 研究采用体外和体内模型,体外测试载4克万古霉素或替考拉宁联合4克头孢他啶、亚胺培南或氨曲南的骨水泥样本的释放特性及抗菌能力。
  • 将体外抗菌能力更优的载抗生素骨水泥间隔器植入8例慢性膝关节假体周围感染患者(4女4男,年龄51至79岁),测量植入后感染部位关节液的抗生素浓度和抗菌活性。

主要发现

  • 载万古霉素与头孢他啶的骨水泥样本体外对测试微生物的抗菌活性持续时间不短于载其他抗生素组合的骨水泥。
  • 关节液样本对包括美国典型培养物保藏中心(ATCC)株和临床分离株在内的细菌表现出活性。

临床怎么用

  • 作者结论认为载万古霉素与头孢他啶的骨水泥是膝关节假体周围感染的潜在有效治疗措施。
  • 临床相关性:本研究确认了载万古霉素与头孢他啶骨水泥间隔器药物递送的潜在有效性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The aim of this study was to determine the optimal formulation of antibiotic-loaded bone cement for knee periprosthetic joint infection. We used both in vitro and in vivo models incorporating various broad-spectrum antibiotics and tested their efficacy against gram-positive and gram-negative bacteria. METHODS: Bone cement specimens loaded with 4 g of either vancomycin or teicoplanin and 4 g of ceftazidime, imipenem, or aztreonam were studied to measure their in vitro antibiotic release characteristics and antibacterial capacities against methicillin-susceptible Staphylococcus aureus, methicillin-resistant Staphylococcus aureus, Staphylococcus epidermidis, Pseudomonas aeruginosa, and Escherichia coli. Bone cement spacers loaded with the antibiotics with the superior in vitro antibacterial capacity were then implanted into 8 patients (4 women and 4 men between 51 and 79 years of age) diagnosed with chronic knee periprosthetic joint infection. The antibiotic concentrations and antibacterial activities in the joint fluid at the site of the infection were measured following spacer implantation. RESULTS: Cement samples loaded with vancomycin and ceftazidime exhibited in vitro antibacterial activity against the test microorganisms that lasted for as long as or longer than that of cement loaded with the other antibiotic combinations. Joint fluid samples exhibited activity against bacteria including American Type Culture Collection (ATCC) strains and clinically isolated strains. CONCLUSIONS: Bone cement loaded with vancomycin and ceftazidime provided broad-spectrum antibacterial capacity both in vitro and in vivo and was shown to be a potentially effective therapeutic measure in the treatment of knee periprosthetic joint infections. CLINICAL RELEVANCE: This study confirmed the potential effectiveness of drug delivery from bone cement spacers impregnated with vancomycin and ceftazidime.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Hsu YH, Hu CC, Hsieh PH, et al. Vancomycin and Ceftazidime in Bone Cement as a Potentially Effective Treatment for Knee Periprosthetic Joint Infection. J Bone Joint Surg Am. 2017. PMID: 28145953. doi:10.2106/JBJS.16.00290

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。